Click here for biographical profiles
Larry Alphs, MD, PhD
Therapeutic Leader, Psychiatry, Janssen Pharmaceutical Companies
Karl Broich, MD
Deputy Head of Federal Institute of Drugs and Medical Devices (BfArM)
Gregory Brown, PhD
Research Associate Professor of Clinical Psychology in Psychiatry, Penn Medicine Neuroscience Center
Adam Butler
Vice President, Client Services, Bracket Global
Kathy Buto, MPA
Vice President for Health Policy, Government Affairs, Johnson and Johnson
Richard Compton
National Highway Traffic Safety Administration
Michael Davidson, MD
Professor of Psychiatry, Department of Psychiatry, Sheba Medical Center, Israel
Nicholas DeMartinis, MD
Director, Pfizer, Inc., Assistant Clinical Professor, University of Connecticut School of Medicine
Susan Dentzer
Editor-in-Chief, Health Affairs Journal
Sarah DuBrava, MS
Associate Director, Clinical Statistics, Pfizer, Inc.
Ronald Farkas, MD, PhD
Lead Medical Officer, Division of Neurology Products, CDER, FDA
Judy Feder, PhD
Professor of Public Policy, Georgetown Public Policy Institute
Reuven Ferziger, MD
CNS Medical Affairs, Janssen Pharmaceutical Companies
George Garibaldi, MD
Global Head Neuroscience, F. Hoffmann LaRoche
Donald Goff, MD
Director, Nathan S. Kline Institute for Psychiatric Research, Vice Chair for Research, Psychiatry Department, NYU Langone Medical Center
Robert Hamer, PhD
Professor of Psychiatry, Research Professor of Biostatistics, University of North Carolina School of Medicine
Ginger Haynes, PhD
Principal Research Scientist, Global Health Outcomes, LBM
Philip D. Harvey, PhD
Professor of Psychiatry, University of Miami Miller School of Medicine
Charles Ingoglia, MSW
Senior Vice President, Public Policy and Practice Improvement, National Council for Community Behavioral Healthcare
Rusty Katz, MD
Director, Division of Neurology Product, Center for Drug Evaluation and Research, US Food and Drug Administration
Richard Keefe, PhD
Professor, Departments of Psychiatry and Behavioral Sciences and Psychology, Duke University Medical Center, President, Neurocog Trials, Inc.
Christopher Kenney, MD
Principal Medical Scientific Expert, Neuroscience, Novartis Pharmaceuticals Corporation
Michael Klein, PhD
Director, Controlled Substance Staff, US Food and Drug Administration
Thomas Kosten, MD
Professor of Psychiatry and Neuroscience, Baylor College of Medicine
Eugene Laska, PhD
Professor, Department of Psychiatry, New York University, Director, Statistical Sciences and Epidemiology Division, Nathan S. Kline Institute for Psychiatric Research, Director, WHO Collaborating Center for Research and Training in Mental Health Management
Thomas Laughren, MD
Division Director, Division of Psychiatric Products, Center for Drug Evaluation and Research, US Food and Drug Administration
Freda Lewis-Hall, MD, FAPA
Executive Vice President, Chief Medical Officer, Pfizer, Inc.
Thomas Macek, PharmD, PhD
Director of Clinical Services, CNS Products, Takeda Global Research and Development
Anil Malhotra, MD
Director of Psychiatry Research, Zucker Hillside Hospital
Ron Manderscheid, PhD
Executive Director, National Association of County Behavioral Health and Developmental Disability Directors
Stephen Marder, MD
Director, Department of Veterans Affairs, VISN 22 Mental Ilness Research, Education and Clinical Center, Professor, Psychiatry, David Geffen School of Medicine, UCLA
David Meltzer, MD, PhD
Chief, Section of Hospital Medicine; Director, Center for Health and Social Sciences; Associate Professor, Department of Medicine and Associate Faculty Member, Harris School and the Department of Economics, University of Chicago
John Messina, PharmD
Vice President of Clinical Development, Optinose
Roger Meyer, MD
Professor of Psychiatry, Pennsylvania State Hershey Medical Center
Joseph Palumbo, MD
Head, Clinical Research, Mitsubishi Tanabe Pharma Development America
Atul Pande, MD
Senior Vice President, GlaxoSmithKline
Mark Pollack, MD
Chairman, Department of Psychiatry, Rush University Medical Center
Holly Posner, MD
Senior Director, Research and Development, Primary Care Busines Unit, Pfizer, Inc.
Stephen G. Potkin, MD
Robert R. Sprague Director of the UCI Brain Imaging Center, Professor of Psychiatry and Human Behavior, and Director of Clinical Psychiatric Research, School of Medicine
Hank Riordan, PhD
Senior Vice President, Medical and Scientific Affairs, Worldwide Clinical Trials, Inc.
Tom Roth, PhD
Director of Research, Sleep Disorders and Research Center at Henry Ford Health System, Henry Ford Hospital Sleep Center
Joe Selby, MD, MPH
Executive Director, Patient-Centered Outcomes Research Institute (PCORI)
Beatrice Setnik
Senior Director, Medical Development, Pfizer
Marta Sokolowska, PhD
Director, Center of Excellence for Abuse Liability, Grunenthal-USA
Michelle Stewart, PhD
Director, Pfizer, Inc.
Robert Temple, MD
Deputy Center Director for Clinical Sciences, US Food and Drug Administration
Jane Tiller, MBChB, FRCPsych
Vice President, Neuroscience, Bristol-Myers Squibb
Joris Verster, PhD
Assistant Professor, Utrecht University
Aristotle Voineskos, MD, PhD, FRCP
Head, Translational Imaging-Genetics Research, Centre for Addiction and Mental Health
David Walling, PhD
Chief Executive and Clinical Officer, Collaborative Neuroscience Network, Inc.
Jeffrey Wefel, PhD, ABPP
Chief ad interim, Section of Neuropsychology, Associate Professor, Department of Neuro-Oncology, M. D. Anderson Cancer Center
Eric Youngstrom, PhD
Professor of Psychology and Psychiatry, University of North Carolina at Chapel Hill, Associate Director, Center of Excellence for Research and Treatment of Bipolar Disorder
Click here for biographical profiles
